GI Clinical Research Studies

Gastrointestinal disorders can cause pain, discomfort, bloating and other discomforting symptoms. There are many different types of GI disorders including gastroparesis, constipation, and bloating. The current GI study at Clinical Research Center of Alabama focuses on the treatment and relief of gastroparesis. Study medication is provided at absolutely no cost, and with no insurance needed. You may also be reimbursed for your time and travel and will receive care from a physician affiliated with Clinical Research Center of Alabama.
For more information on any of the following eczema clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing wodonnell@alabamaallergy.com

Oral medication Study

Ages 19-70

Vanda gi
The purpose of this study is to determine the effectiveness of Tradipitant, an oral medication, in treating symptoms of gastroparesis.

Investigational Antibody Injection

Ages 12-80

Allakos EOE
The main purpose of this study is to see how safe the new investigational drug, AK002 is, and how it affects the number of eosinophils in the esophagus. AK002 is an intravenous drug, meaning that is given through a needle placed in your vein. AK002 is a humanized antibody, which is a protein produced by the body’s immune system that recognized and helps fight infections and other foreign substances in the body.

Become a Participant in our GI Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.